Azithromycin for mild-to-moderate COVID-19 - Authors' reply

Ítems similars

• Azithromycin for mild-to-moderate COVID-19: author's reply
  per: Hinks, TSC, et al.
  Publicat: (2021)
• Azithromycin in viral infections
  per: Oliver, ME, et al.
  Publicat: (2020)
• Hydroxychloroquine with azithromycin in patients hospitalized for mild and moderate COVID-19
  per: Elisa Baranski Lamback, et al.
  Publicat: (2021-03-01)
• Azithromycin versus standard care in patients with mild-to-moderate COVID-19 (ATOMIC2): an open-label, randomised trial
  per: Hinks, TSC, et al.
  Publicat: (2021)
• Author’s Reply—Is it really COVID-19?
  per: David Chang, MD, et al.
  Publicat: (2020-07-01)